Credit Suisse’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.62M | Buy |
112,301
+16,543
| +17% | +$533K | ﹤0.01% | 1476 |
|
|
2023
Q4 | $2.75M | Buy |
95,758
+22,145
| +30% | +$635K | ﹤0.01% | 1692 |
|
|
2023
Q3 | $2.04M | Sell |
73,613
-16,893
| -19% | -$468K | ﹤0.01% | 1822 |
|
|
2023
Q2 | $2.42M | Buy |
90,506
+20,606
| +29% | +$551K | ﹤0.01% | 1771 |
|
|
2023
Q1 | $1.51M | Buy |
69,900
+12,896
| +23% | +$279K | ﹤0.01% | 2031 |
|
|
2022
Q4 | $1.36M | Buy |
57,004
+1,130
| +2% | +$26.9K | ﹤0.01% | 2116 |
|
|
2022
Q3 | $1.1M | Buy |
55,874
+15,366
| +38% | +$303K | ﹤0.01% | 2240 |
|
|
2022
Q2 | $790K | Sell |
40,508
-4,672
| -10% | -$91.1K | ﹤0.01% | 2524 |
|
|
2022
Q1 | $1.15M | Sell |
45,180
-1,124
| -2% | -$28.7K | ﹤0.01% | 2440 |
|
|
2021
Q4 | $1.17M | Buy |
46,304
+14,151
| +44% | +$356K | ﹤0.01% | 2485 |
|
|
2021
Q3 | $884K | Buy |
32,153
+4,771
| +17% | +$131K | ﹤0.01% | 2663 |
|
|
2021
Q2 | $869K | Buy |
27,382
+11,641
| +74% | +$369K | ﹤0.01% | 2724 |
|
|
2021
Q1 | $723K | Sell |
15,741
-36,545
| -70% | -$1.68M | ﹤0.01% | 2750 |
|
|
2020
Q4 | $2.07M | Buy |
52,286
+29,698
| +131% | +$1.18M | ﹤0.01% | 2103 |
|
|
2020
Q3 | $787K | Buy |
22,588
+15,065
| +200% | +$525K | ﹤0.01% | 2422 |
|
|
2020
Q2 | $237K | Buy |
+7,523
| New | +$237K | ﹤0.01% | 3040 |
|